# A Study of CDX-622 in Participants With Mild to Moderate Asthma

> **NCT07330778** · PHASE1 · RECRUITING · sponsor: **Celldex Therapeutics** · enrollment: 12 (estimated)

## Conditions studied

- Mild to Moderate Asthma

## Interventions

- **DRUG:** CDX-622

## Key facts

- **NCT ID:** NCT07330778
- **Lead sponsor:** Celldex Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-02
- **Primary completion:** 2027-03
- **Final completion:** 2027-03
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2026-04-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07330778

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07330778, "A Study of CDX-622 in Participants With Mild to Moderate Asthma". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07330778. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*